Genetron Health to Present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit
BEIJING, April 01, 2021 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present at the SVB Leerink CybeRx Series: Liquid Biopsy & Oncology Dx Summit on Wednesday April 7th, 2021.
Interested parties may request more information by contacting their sales representative at SVB Leerink.
About Genetron Holdings Limited
Safe Harbor Statement
Investor Relations Contact
David Deuchler, CFA
Keynote Presentation TBA
Keynote Presentation - Eric Burger, Former FCC CTO
Exhibit Hall Open